EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma

Chaozhi Tang iD, Yifan Liu iD, Tian-Long Wang, Jiakang Ma, Weihua Chen, Xiang Liu iD, Jingdong Xue iD, Lin Ye iD, Feng Yue iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/2797474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 27.05.2026. Verfasst von Chaozhi Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China, tongji.edu.cn. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At the transcriptomic level, several molecular subtyping schemes have been established to elucidate the intrinsic heterogeneity of urothelial carcinoma and to inform prognostic assessment and therapeutic guidance. However, a unified molecular classification scheme characterizing genomic alterations is lacking. Unsupervised and supervised clustering identified two distinct mutational signature subtypes. Kaplan–Meier analysis demonstrated that patients with the MUT2 subtype had a higher risk of death than those with the MUT1 subtype across multiple cohorts, including IMvigor210 (hazard ratio [HR], 1.74; 95% confidence interval [CI], 1.27–2.37; p < 0.001), UC‐GENOME (HR, 1.54; 95% CI, 0.93–2.54; p = 0.091), The Cancer Genome Atlas (TCGA; HR, 1.45; 95% CI, 1.06–1.98; p = 0.020), MSK2022 (HR, 1.34; 95% CI, 1.10–1.64; p = 0.004), MSK2015 (HR, 3.43; 95% CI, 1.36–8.64; p = 0.005), and the Tongji cohort (HR, 4.99; 95% CI, 0.57–43.69; p = 0.11). Immunotherapy response rates were significantly higher in the MUT1 subtype than in the MUT2 subtype in IMvigor210 (31.8% vs. 13.1%; p = 0.003) and UC‐GENOME (42.3% vs. 29.0%; p = 0.022). Consistent with these findings, single‐cell analysis showed that MUT2 tumors were enriched in tumor‐associated fibroblast subpopulations and had a lower abundance of immune effector cells. Overall, this genomic analysis identified two mutation‐based subtypes of urothelial carcinoma associated with patient prognosis and immunotherapy response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsSingle-Cell AnalysisHumansMaleFemaleSmokersPrognosisCluster AnalysisMutationUnsupervised Machine LearningTumor MicroenvironmentMiddle AgedAgedSurvival Analysis

Stichwörter der Autor:innen

immunotherapy responseprognostic assessmentsignature subtypesurothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China, tongji.edu.cn.
  • Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China, tongji.edu.cn.
  • Department of Urology, Shanghai Eighth People's Hospital, Shanghai, China.
  • The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Shanghai, China, haust.edu.cn.
  • Department of Urology, Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China, tongji.edu.cn.
  • Department of Urology, The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, Guangdong, China, gzhmc.edu.cn.

ORCID-Profile: Chaozhi Tang, Yifan Liu, Xiang Liu, Jingdong Xue, Lin Ye, Feng Yue

Zitieren

APA

Tang, C., Liu, Y., Wang, T. L., Ma, J., Chen, W., Liu, X., Xue, J., Ye, L., & Yue, F. (2026). Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma. Human Mutation, 2026(1). https://doi.org/10.1155/humu/2797474

Vancouver

Tang C, Liu Y, Wang TL, Ma J, Chen W, Liu X, et al. Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma. Human Mutation. 2026;2026(1). doi:10.1155/humu/2797474

BibTeX
@article{Tang2026,
  author = {Tang, Chaozhi and Liu, Yifan and Wang, Tian-Long and Ma, Jiakang and Chen, Weihua and Liu, Xiang and Xue, Jingdong and Ye, Lin and Yue, Feng},
  title = {Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/2797474}
}
Kostenlos starten →